Tomlinson S, Raper J
Department of Pathology, NYU Medical Center, New York 10016, USA.
Nat Biotechnol. 1996 Jun;14(6):717-21. doi: 10.1038/nbt0696-717.
The natural immunity of humans to the cattle pathogen Trypanosoma brucei brucei, but not to the morphologically indistinguishable human pathogens T. brucei gambiense and T. brucei rhodesiense, is due to the selective killing of the parasite by normal human serum. The factor in human serum that mediates lysis of T. brucei brucei has long been attributed to a minor subclass of high density lipoprotein (HDL). Evidence indicates that the trypanolytic activity of isolated human HDL is due to peroxidase activity of an associated haptoglobin-related protein-hemoglobin complex. However, recent data suggest that the trypanolytic activity of HDL may be completely inhibited in whole human serum, and that trypanolytic activity of norman human serum is due to a second, less well-defined factor of high molecular weight. Current research aimed at understanding the mechanisms of cytotoxicity and the affected metabolic pathways may open new approaches for the development of specific drugs and vaccines against trypanosomiasis.
人类对牛病原体布氏布氏锥虫具有天然免疫力,但对形态上难以区分的人类病原体冈比亚布氏锥虫和罗得西亚布氏锥虫却没有免疫力,这是由于正常人血清对该寄生虫的选择性杀伤作用。长期以来,人们一直认为人血清中介导布氏布氏锥虫裂解的因子是高密度脂蛋白(HDL)的一个小亚类。有证据表明,分离出的人HDL的锥虫溶解活性归因于相关触珠蛋白相关蛋白-血红蛋白复合物的过氧化物酶活性。然而,最近的数据表明,HDL的锥虫溶解活性在整个人血清中可能会被完全抑制,而且正常人血清的锥虫溶解活性归因于另一种分子量较大、定义不太明确的因子。目前旨在了解细胞毒性机制和受影响代谢途径的研究可能会为开发针对锥虫病的特效药物和疫苗开辟新途径。